Parallel Health World News Logo
update

Parallel Health World

cropper
update
  • Home
  • Categories
    • EcoHealth Trends
    • Healing Naturally
    • Age-Defying Diets
    • Supplement Savvy
    • Mind-Body Synergy
    • Finance and Health
    • Biolimitless
    • Tech Hacks
    • Health & Medicine
    • Political
    • BioBuzz
    • Holistic Rehabilitation Techniques
    • Practitioner Insights
    • AI In Healthcare
  • Featured Business Profiles
1 Minute Read

Biolimitless New Path To Health

Discover a New Path to Health with Dr. Eric Nepute and BioLimitless




Transcript: You know, it's been said that knowledge is power, but wisdom is taking that knowledge and applying it to your life. And without that knowledge, our people will perish. We also know that the Latin meaning of the word doctor is teacher, and your doctor's job is to teach, reach, and inspire, and motivate you to get that knowledge and wisdom and to change your life and the life of your family? And what if I told you that the majority of the things that you learned about health, about healing, about wellness was wrong or maybe even a lie?

Hi. My name is doctor Eric Napputi, and I've dedicated my life to helping people get to the root cause of their problems.

And human suffering. And I've really gone about this in a very non conventional way. Let me tell you a little bit about my background.

Ever since I was a child, I've always wanted to be a physician. I've always wanted to help people solve their problems. But when I started my conventional medical training, it just didn't answer the question, why? And that's where my outside of the box non conventional health and wellness training started.

You see, not only my primary care provider, but I also have a doctorate in natural medicine, a doctorate in chiropractic, a fellowship in functional neurology, a fellowship in internal health. I'm a certified athletic trainer. I've got a master's in clinical nutrition and three bachelor's degrees in human anatomy, sports medicine, and chemistry. And I don't tell you that to impress you, but to impress upon you that I think and act differently because of that.

Not only do I have a very diverse educational background, but my business background is very unique as well. I've owned and operated over thirty of my own health and wellness centers. They're fully integrated practices, but people would come from all over the world to be seen. I've owned and operated surgical centers across the United States.

I've been a part owner of a nutraceutical company. I've owned part of a hospital system. I've been involved with pharmaceutical, biological companies.

I've helped train thousands of doctors across the globe on how to get to the root cause of chronic illness. And as of recently, I've been honored to be a part of the Make America Healthy Again campaign where secretary of health and human services, Bobby Kennedy Junior, has asked me to be a part of the movement to help eradicate chronic illness and childhood illness across the globe. I've also testified in front of Congress at a federal and a state level to help improve policies and remove some of the unnecessary regulations so that people can actually get to the root cause of their problems and not just manage the diseases.

Over the past two decades, I've dedicated my life to understanding the human body at its most fundamental level. I've always been driven by one mission and that's to find the root cause of health issues, not just treat the symptoms. Now, let me ask you this. Have you or anyone you know ever struggled with fatigue, brain fog, weight gain, hormonal imbalances, digestive issues, leaky gut problems, chronic pain, low libido, anxiety, mood swings, autoimmune disorders, hypertension, heart disease, or liver and kidney issues. I know the list is long, but what if I told you there was a company backed by real science and real results that can help you with all of these issues and much more.

Welcome to BioLimimus.

I've seen firsthand how powerful the right approach can be and that's exactly what I want to talk to you about with BioLimimus.

Because the more you understand about how you are and how your body works, the better you can help yourself and help your family. Because self care is the real health care, and it begins with understanding about you. At Bio Limitless, we offer unique technologies backed by research and designed to help tens of thousands of people get better every single day. Let me tell you a little bit about some of the products and how they work. Let's first talk about our cellular the reset formula. Cellular the reset is not like any typical metabolic or performance supplement on the market. It's a peptide based bioregulator formula designed to work at a cellular level by combining strategic peptides in a specific manner in order to improve mitochondria, improve cellular repair, and improve metabolism.

Some of the amazing results that you're going to have with that is rapid fat loss. We're gonna shift your body from a sugar burner to a fat burner without losing muscle mass. In fact, our peptide blend has an exercise in a bottle in it where it literally mimics exercise and helps your body build muscle while burning fat at the same time and helping systemically reduce inflammation, which accelerates tissue recovery and improves endurance, helping your body rest, recharge, and operate at its full biologic potential.

Now let's talk a little bit about our cell signals formula. This is a revolutionary bioregulator formula designed to optimize cellular communication and restore cellular efficiency, supporting energy, performance and systemic balance in the human body. Listen. As we age, the production of key cell signaling molecules decline, dropping by ninety percent or more by the age of thirty.

This disrupts our cells' ability to vibrate at a frequency for energy production, detoxification, and repair. And these changes contribute to fatigue, brain fog, slower recovery, and other age related challenges. Cell signal combines bioavailable nutrients to offset those issues and help restore optimal performance of the human body. Now I'm sure many of you know that we're living in an era where anxiety, depression, insomnia, and mental illness are off the charts and rising.

Our NeuroReboot formula is a potent tripeptide bioregulator formula designed to help rewire brain function, refire metabolic processes, and reboot cellular regeneration.

This advanced blend of peptides works synergistically to restore balance at a cellular level, helping you think clearer, feel stronger, and perform at your best. This formula helps cellular renewal restoration, helps metabolic activation, cognitive function optimization.

It connects the brain gut axis, which helps maintain the communication between the neuro transmitters of your gut and your brain and it helps with cellular vitality and is the key to longevity.

Now since we're speaking of the brain gut connection, let me tell you about one of my favorite formulas, our master microbiotic formula. It is a clinically validated bioregulator formula designed to optimize gut health and recolonize the microbiome with potent spore based master microbes and is supported by gut healing regenerative peptide peptide known as BPC one five seven, the healing peptide.

Utilizing our patented phytomicroencapsulation technology, this formula delivers beneficial probiotics directly into the small intestine where we need them the most. This formula helps restore gut health, boost immune system, and enhances overall well-being in the human body.

Now in our increasingly toxic world, we are bombarded with harmful substances every single day from heavy metals to microplastics to pesticides, herbicides, larvicides, fungicides, all these chemical toxins that make us toxic. Over ninety percent of Americans have detectable levels of harmful chemicals in their body that is literally killing them. Our detox pro plus formula is built to combat this toxic burden and support natural detoxification in a safe daily usable formula scientifically backed with ingredients that bind and remove toxins while restoring balance at a cellular, genetic, and microbial level. This advanced blend also supports mitochondrial function, healthy inflammation markers, and promotes gut and liver detoxification processes. By targeting the root cause of toxic accumulation, detox pro plus helps restore energy, strengthen immune function, and revitalize overall well-being while empowering the human body to function properly.

Now unlike most healthcare experts at Bio Limitless, we test, we don't guess. Now I'm not here to discredit traditional healthcare, but if you've been searching for a better way, one that understands how your body works at a genetic and cellular level, then Bio Limitless is the answer.

At BioLimulus, we know that true health starts within you. You have the power to transform your life, but it has to start with you. Self care reimagine begins with you understanding more about yourself. Our bioliminalist DNA discovery kit measures over eight hundred thousand genetic markers in your body and gives you the map and the blueprint how to live your life.

If you don't understand how to live your genetic lifestyle, I don't care what vitamins, minerals, and supplements you take, you're not optimizing your production. What if there was a test that you could take from home that could measure how you should sleep, how you should exercise, what supplements you should have, when you should take them, what types of injuries your body's prone to, and much, much more. This test by itself has been an absolute game changer for thousands of my patients, and it'll be a game changer for you as well. At BioLimulus, we know that health starts from within.

You have the power to transform your health, but it has to start with you. So let's get started today. Go to the link below, explore the products, and join the thousands who have found a better path to health with biolimimus. Click the link, take control of your health, and transform your life because self care is the real health care.


Biolimitless Selfcare
Biolimitless

746 Views

0 Comments

Write A Comment

*
*
Please complete the captcha to submit your comment.
Related Posts All Posts
04.23.2026

Phio Pharmaceuticals Revolutionizes Cancer Treatment with INTASYL Technology

Update Phio Pharmaceuticals: Pioneering the Future of Cancer Treatment In the evolving landscape of cancer therapeutics, Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is emerging as a formidable player. The company's innovative approach leverages its INTASYL® gene silencing technology to combat various forms of cancer. During the upcoming Renmark Financial Communications Live Virtual Non-Deal Roadshow on April 29, 2026, CEO Robert Bitterman will delve into Phio's groundbreaking treatments, particularly focusing on their lead candidate, PH-762, which is currently under evaluation for cutaneous squamous cell carcinoma (cSCC), melanoma, and Merkel cell carcinoma. Understanding INTASYL: A Novel Gene Silencing Technology At the heart of Phio's developments is its INTASYL® technology, which is designed to silence the PD-1 gene, a significant player in the immune response related to various cancers. This technology enhances the body's immune cells, making them more effective in targeting and eliminating cancer cells. The Phase 1b clinical trial results indicate promising potential, showing a significant pathological response rate in patients treated with PH-762. According to recent communications, out of 22 patients treated so far, a notable 65% exhibited a pathological response. Specifically, six out of seven patients in the highest dosing cohort achieved remarkable results, exhibiting an 85% pathological response, which indicates that the technology could provide a non-surgical alternative for treating skin cancers. Recent Milestones: Pathological Responses and Safety Considerations Phio’s continual updates emphasize the importance of monitoring safety alongside efficacy. As detailed in the previous reports, the comprehensive safety reviews confirmed no serious adverse effects or dose-limiting toxicities throughout the study. This finding is particularly significant as it highlights the drug's potential as a safe treatment alternative in a domain where such attributes are pivotal. Further insights into the Phase 1b trial illustrate that among the patients with cutaneous carcinomas who completed treatment, a cumulative 100% clearance was achieved in one patient, with two others displaying greater than 90% and 50% clearance rates respectively. This progress not only signifies a breakthrough in application but also positions Phio as a key player in the fight against skin cancers. Live Virtual Non-Deal Roadshow: A Platform for Visibility The upcoming presentation offers an excellent opportunity for investors and stakeholders to engage directly with Phio's leadership. Bitterman’s presentation will not only cover the clinical advancements of INTASYL but also outline the company’s strategic plans for future development. The interactive Q&A format will likely illuminate further details regarding ongoing clinical trials and overall company direction. In a field where transparency and communication regarding advancements are crucial, such public forums serve as vital conduits of information to the investor community and patients alike. Future Directions: What Lies Ahead for Phio? The presentation on April 29, 2026, could indeed provide forward-thinking observers insights into expected milestones such as the timing for FDA submissions and the next steps in clinical study designs related to PH-762. As the field of immuno-oncology continues to evolve, keeping a close watch on Phio's progression could yield insights into emergent treatment paradigms that revolutionize cancer therapy. With the ongoing development of therapeutic alternatives to traditional surgery, the advances made by Phio Pharmaceuticals warrant attention. As clinical results continue to unfold, they may pave the way for more effective, less invasive options that could ultimately change the landscape of cancer treatment. Conclusion: The Case for Continued Vigilance in Cancer Treatments The fight against cancer is multifaceted, necessitating an array of innovative solutions. Phio Pharmaceuticals signifies a beacon of hope in this landscape with its commitment to advancing its INTASYL technology and providing updated, actionable information through various channels, including the upcoming roadshow. Maintaining awareness and engagement with organizations like Phio could foster a greater understanding of the next wave of cancer therapies.

04.22.2026

PreveCeutical's Non-Brokered Private Placement: Key Insights for Health Investors

Update PreveCeutical's New Private Placement: What It Means for Investors PreveCeutical Medical Inc. is entering an exciting phase of growth as it announces a non-brokered private placement that aims to raise up to $1 million by offering 40 million units at a price of $0.025 each. This financing move is part of the company's strategic initiatives to bolster its research and development programs, which focus on innovative solutions in preventive health. Understanding the Offering Each unit in this offering consists of one common share and half of a share purchase warrant. This means investors not only part with cash now but also secure the option to purchase additional shares in the future at $0.05, provided certain conditions are met. This structure is designed to engage investors by providing potential upside should PreveCeutical’s stock perform well on the market. However, it also places a degree of risk on the investor, as the main motivation for such an offering lies in the realization of the company’s objectives and operational turnaround for which the proceeds will be allocated. Why This Matters: The Purpose of the Funds The proceeds from the private placement will primarily support short-term loan repayments, audit and legal fees, and further studies involving rodents and tissues. However, a significant portion is earmarked for patent development and other vital initiatives shaping the future of PreveCeutical’s health science innovations. PreveCeutical is not just focused on financial gain; it aims to revolutionize the health sciences sector with five ongoing research and development programs. These include gene therapies targeting diabetes and obesity, therapeutic peptides, and non-addictive alternatives for pain management. Indeed, the implications of these advancements extend well beyond interim finances, as the potential applications for these therapies could change patient care paradigms in significant ways. A Look at PreveCeutical's Innovations This financing round takes place within a broader context of rapidly advancing biotechnologies, particularly in how they relate to preventive health measures. PreveCeutical is poised to impact the market positively with its focus on: Dual Gene Therapy: Aimed at curbing diabetes and obesity—two of the leading health crises globally. Nature Identical Peptides: Harnessing the potential for innovative treatments that align closely with organic health products. Concussion Therapeutics: Developing methods to aid athletes suffering from mild traumatic brain injuries. These areas make PreveCeutical a compelling entity to watch as its innovations could usher in new healthcare solutions that emphasize prevention and comfort rather than risky interventions. Market Conditions and Future Predictions The financing will also help PreveCeutical maneuver through regulatory paths that enable it to protect and commercialize its discoveries more efficiently. Investors and stakeholders should keep a close eye on the Canadian Securities Exchange (CSE), where the company's performance can act as a bellwether for its operational success. Should PreveCeutical’s share price reach $0.10 for ten consecutive days, investors will see an acceleration in the Warrant expiry timeline, which adds another layer of incentive. Nonetheless, these speculative aspects of the offering come with inherent risks—especially in a field as dynamic and unpredictable as biotechnology. Conclusion: The Strategic Move Forward The decision to pursue this non-brokered private placement reveals PreveCeutical’s commitment not just to immediate financial health but to a responsible growth pathway poised for impactful breakthroughs in preventive medicine. Investors interested in health technology innovation should consider evaluating PreveCeutical’s public communications and financial health as it embarks on this essential funding journey. This offering isn't just about monetary transactions; it symbolizes a step towards redefining health solutions that could ultimately progress our approach to well-being. As an investor, staying informed poses the best strategy, allowing you to make educated decisions aligned with the future developments of PreveCeutical.

05.24.2026

Nualtis Corp. is Poised for Growth at the 2026 Healthcare Investor Conference

Update Understanding Nualtis Corp’s Role in the Healthcare Landscape Nualtis Corp., based in Montreal, is not just another name in the pharmaceutical sector. It specializes in creating innovative oral dissolvable film (ODF) technologies that aim to revolutionize drug delivery systems. With a foundation built on over a decade of experience in formulation and manufacturing, Nualtis helps extend product lifecycles for pharmaceuticals, addressing both the market needs and the realities of patient care. Highlighting the 2026 Bloom Burton & Co. Healthcare Investor Conference This year’s Bloom Burton & Co. Healthcare Investor Conference set to take place on April 21 and 22 at the Metro Toronto Convention Centre, promises to be a pivotal event in the Canadian healthcare investment landscape. This gathering will showcase presentations from leading companies like Nualtis who are at the forefront of innovation. With Dr. Michael Raven, CEO of Nualtis, scheduled to speak on Tuesday at 3:30 PM ET, this session is not to be missed by investors seeking insights into the future of drug delivery technologies. Diverse Engagement Opportunities for Investors Beyond the presentations, the event will offer a platform for one-on-one meetings, where companies like Nualtis can engage directly with investors. Such interactions are essential for potential investors looking to form strategic partnerships or even entry points into the biotech market. Nualtis’ commitment to establishing these connections underscores the company’s proactive approach to stakeholder engagement and growth. The Importance of Innovative Drug Delivery The oral dissolvable film technology that Nualtis specializes in represents a shift in how medicines can be delivered, particularly for populations with swallowing difficulties or those needing rapid drug absorption. The company aims to pave the way for treatment methods that are more accessible and patient-friendly, aligning with global trends towards personalized and efficient healthcare solutions. Investor Trends and Future Insights As the healthcare sector itself evolves, driven by technology and patient-centered care, conferences like Bloom Burton highlight the urgency with which investors and companies must adapt. Trends show increasing interest in sectors focusing on innovative technologies, like those offered by Nualtis. Investors may find that companies adept at utilizing cutting-edge drug delivery systems have a competitive advantage, particularly as healthcare systems seek solutions that enhance patient adherence and outcomes. Why Nualtis Stands Out in a Competitive Market Nualtis Corp. prides itself on its integrated approach, providing not just drug development but also regulatory support and analytical services. This ability to offer a comprehensive package from lab to market accelerates timelines and improves the likelihood of successful product launches. Within a market rife with complexities and challenges, Nualtis represents hope for innovative solutions that truly aim to enhance the therapeutic landscape. As the Bloom Burton & Co. Healthcare Investor Conference approaches, this could be the perfect opportunity to keep an eye on companies like Nualtis, as they unveil their future strategies and innovations that could reshape the healthcare industry. If you are an investor looking for the next growth opportunity in the healthcare sector, attending the conference and connecting with companies like Nualtis could provide invaluable insights.

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*